Suchergebnisse - "Virus Diseases"

PubPharm (16.889)

71

A Study of JNJ-73763989, Pegylated Interferon Alpha-2a and Nucleos(t)Ide Analogs in Participants With Chronic Hepatitis B Virus Infection : A Phase 2, Open-label, Multicenter Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of Treatment With JNJ-73763989, Nucleos(t)Ide Analogs, and Pegylated Interferon Alpha-2a in Patients With Chronic Hepatitis B Virus Infection

enthalten in: ClinicalTrials.gov | 2024

72

Adoptive T-cell Therapy for Resistant Viral Infections After Allogeneic HSCT : Virus-specific T-cell Immunity for the Treatment of Some Resistant Viral Infections After Allogeneic Hematopoietic Stem Cell Transplantation(HSCT)

enthalten in: ClinicalTrials.gov | 2024

73

A Study to Assess Intrahepatic and Peripheral Changes of Immunologic and Virologic Markers in Chronic Hepatitis B Virus Infection : A Phase 2 Randomized, Open-label, Parallel-group, Multicenter Study to Assess Intrahepatic and Peripheral Changes of Immunologic and Virologic Markers in Response to Combination Regimens Containing JNJ-73763989 and Nucleos(t)Ide Analog With or Without JNJ-56136379 in Patients With Chronic Hepatitis B Virus Infection

enthalten in: ClinicalTrials.gov | 2024

74

Is the phone mightier than the virus? : cellphone access and epidemic containment efforts

enthalten in: Journal of development economics | 2024

von Gonzalez, R. | Maffioli, E.

75

Calibration of Prediction Models of In-hospital Mortality in SARS-CoV-2 Patients Depends also on Data Quality

enthalten in: Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine | 2024

von Finsterer, J. | Scorza, F.

76

The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise : The Natural History of Severe Viral Infections and Characterization of Immune Defects

enthalten in: ClinicalTrials.gov | 2024

77

A Study of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in Children 2 to <18 Years of Age at High Risk of Respiratory Syncytial Virus : A Phase 2, Randomized, Observer-blind Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in Children 2 to <18 Years of Age at High Risk of Respiratory Syncytial Virus Disease

enthalten in: ClinicalTrials.gov | 2024

78

Impact of COVID-19 Infections among Unvaccinated Patients with Congenital Heart Disease : Results of a Nationwide Analysis in the First Phase of the Pandemic

enthalten in: Journal of clinical medicine | 2024

von Fischer, A. | Hellmann, A. | Diller, G. | +6

79

Viral Infections in Healthy and Immunocompromised Hosts : Viral Infections in Healthy and Immunocompromised Hosts

enthalten in: ClinicalTrials.gov | 2024

80

RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection : A Trial in Participants With Chronic Obstructive Pulmonary Disease (COPD) to Evaluate the Impact of Vapendavir on the Development of Lower Respiratory Tract Symptoms Following Rhinovirus Challenge

enthalten in: ClinicalTrials.gov | 2024